Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn’s DiseaseZhigang Wang, Erwin Dreesen, Wei Zhang et al.|Clinical Gastroenterology and Hepatology|2025Cited by 3